1. Home
  2. TNL vs IRON Comparison

TNL vs IRON Comparison

Compare TNL & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travel   Leisure Co.

TNL

Travel Leisure Co.

HOLD

Current Price

$73.08

Market Cap

4.9B

ML Signal

HOLD

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$66.38

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNL
IRON
Founded
1990
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.9B
3.0B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
TNL
IRON
Price
$73.08
$66.38
Analyst Decision
Buy
Strong Buy
Analyst Count
8
13
Target Price
$77.75
$99.54
AVG Volume (30 Days)
626.7K
943.0K
Earning Date
05-21-2026
05-29-2026
Dividend Yield
3.26%
N/A
EPS Growth
N/A
N/A
EPS
3.44
N/A
Revenue
$4,021,000,000.00
N/A
Revenue This Year
$4.73
N/A
Revenue Next Year
$3.32
$215.03
P/E Ratio
$21.33
N/A
Revenue Growth
4.06
N/A
52 Week Low
$37.77
$30.82
52 Week High
$81.00
$99.50

Technical Indicators

Market Signals
Indicator
TNL
IRON
Relative Strength Index (RSI) 49.39 43.58
Support Level $70.31 $57.45
Resistance Level $74.82 $82.70
Average True Range (ATR) 2.54 6.10
MACD -0.01 0.27
Stochastic Oscillator 26.19 73.52

Price Performance

Historical Comparison
TNL
IRON

About TNL Travel Leisure Co.

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: